These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20089590)

  • 21. [Economic prescription of drugs].
    Sonne J; Faber O
    Ugeskr Laeger; 2004 Apr; 166(18):1695. PubMed ID: 15174414
    [No Abstract]   [Full Text] [Related]  

  • 22. Save green, go generic: be prepared to answer the $4 question.
    Hansen D
    S D Med; 2009 Nov; 62(11):436-7. PubMed ID: 20128174
    [No Abstract]   [Full Text] [Related]  

  • 23. Compensation for switching patients to generic drugs.
    Tenn Med; 2008 Jul; 101(7):9-10. PubMed ID: 18649620
    [No Abstract]   [Full Text] [Related]  

  • 24. Hospital doctors: know cost of drugs and NARA values.
    Igoe G
    Ir Med J; 1998; 91(1):28-9. PubMed ID: 9563255
    [No Abstract]   [Full Text] [Related]  

  • 25. Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals?
    Granlund D
    Soc Sci Med; 2009 Dec; 69(11):1643-50. PubMed ID: 19815322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmaceutical promotion and GP prescription behaviour.
    Windmeijer F; de Laat E; Douven R; Mot E
    Health Econ; 2006 Jan; 15(1):5-18. PubMed ID: 15945041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutting drug costs. Brand names go generic.
    Mayo Clin Health Lett; 2008 Dec; 26(12):7. PubMed ID: 19174846
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications.
    Godman B; Shrank W; Andersen M; Berg C; Bishop I; Burkhardt T; Garuoliene K; Herholz H; Joppi R; Kalaba M; Laius O; McGinn D; Samaluk V; Sermet C; Schwabe U; Teixeira I; Tilson L; Tulunay FC; Vlahović-Palčevski V; Wendykowska K; Wettermark B; Zara C; Gustafsson LL
    Expert Rev Pharmacoecon Outcomes Res; 2010 Dec; 10(6):707-22. PubMed ID: 21155704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The rise of the generic drug market and its implications for dermatology.
    Bhosle M; Balkrishnan R; Dewan T; Yelverton CB; Feldman SR
    J Dermatolog Treat; 2005; 16(5-6):295-8. PubMed ID: 16428148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generic atypical antipsychotic drugs in Belgium: their influence and implications.
    Godman B; De Bruyn K; Miranda J; Raschi E; Bennie M; Barbui C; Simoens S
    J Comp Eff Res; 2013 Nov; 2(6):551-61. PubMed ID: 24236794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generic medicines: Greek physicians' perceptions and prescribing practices.
    Tsiantou V; Zavras D; Kousoulakou H; Geitona M; Kyriopoulos J
    J Clin Pharm Ther; 2009 Oct; 34(5):547-54. PubMed ID: 19744010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Copayment coupons undermine formularies.
    Manag Care; 2011 Dec; 20(12):63. PubMed ID: 22259878
    [No Abstract]   [Full Text] [Related]  

  • 33. Out-of-pocket costs to users: medicine options for hypertension.
    Arredondo A
    Am J Hypertens; 2008 May; 21(5):492. PubMed ID: 18437138
    [No Abstract]   [Full Text] [Related]  

  • 34. [Scope of the contract for drug therapy. Rebate contracts also for original drugs].
    MMW Fortschr Med; 2009 Jul; 151(30-33):80. PubMed ID: 19722473
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prescription of generic drugs in general practice. Results of a survey of general practitioners].
    Simmenroth-Nayda A; Hummers-Pradier E; Ledig T; Jansen R; Niebling W; Bjerre LM; Kochen MM; Himmel W
    Med Klin (Munich); 2006 Sep; 101(9):705-10. PubMed ID: 16977394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physicians, the industry and population health.
    Gérvas J; Mansfield PR
    J Epidemiol Community Health; 2009 Oct; 63(10):773-4. PubMed ID: 19749125
    [No Abstract]   [Full Text] [Related]  

  • 37. Going over the patent cliff.
    Schommer JC
    Minn Med; 2011 Oct; 94(10):42-3. PubMed ID: 23256283
    [No Abstract]   [Full Text] [Related]  

  • 38. Health care costs.
    Shallcross DL
    J S C Med Assoc; 2003 Dec; 99(12):383. PubMed ID: 14983529
    [No Abstract]   [Full Text] [Related]  

  • 39. Changes in drug prescribing under the Public Health Reform Law--a survey of general practitioners' attitudes in East and West Germany.
    Himmel W; Kron M; Thies-Zajonc S; Kochen MM
    Int J Clin Pharmacol Ther; 1997 Apr; 35(4):164-9. PubMed ID: 9112138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescribing costs.
    Malcolm L
    N Z Med J; 1998 Mar; 111(1061):83. PubMed ID: 9575063
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.